COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00129753
Brief Title: Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease

First Submitted : August 11, 2005
First Submitted that Met QC Criteria : August 11, 2005
First Posted : August 12, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : November 6, 2018
Last Update Posted : November 8, 2018